GlassScriptPhysician profile
Joseph A Ball
NPI 1447254230
$24,433.99
in general payments reported to CMS, 2019-2025
53 companies · $4,556 in 2025
The $4,556 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,217 · 2020: $2,765 · 2021: $3,123 · 2022: $3,413 · 2023: $3,625 · 2024: $3,736 · 2025: $4,556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,475.34 |
| Education | $441.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,019.92 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $3,512.67 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $2,149.65 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,933.17 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $1,449.41 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $1,290.20 | 2019-2025 | Prolastin-C Liquid, Gamunex-C, Xembify |
| Mylan Specialty L.P. | $1,214.39 | 2019-2024 | Yupelri |
| Genzyme Corporation | $1,186.88 | 2019-2025 | |
| Insmed, INC. | $1,167.75 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $819.04 | 2022-2025 | Tezspire, Tavneos, Lumakras |
| United Therapeutics Corporation | $780.26 | 2019-2025 | Tyvaso, Tyvaso |
| Ani Pharmaceuticals, INC. | $657.90 | 2022-2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $458.98 | 2019-2025 | |
| Pfizer INC. | $393.86 | 2020-2025 | |
| Mallinckrodt Hospital Products INC. | $368.59 | 2020-2025 | Acthar |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $291.94 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $279.77 | 2020-2025 | Glassia |
| Sanofi-Aventis U.S. LLC | $218.56 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $202.47 | 2022-2025 | Dificid, Winrevair, Verquvo |
| Electromed, INC. | $189.49 | 2019-2025 | Smartvest |
| Verona Pharma, INC. | $171.52 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $170.26 | 2019-2020 | |
| Axsome Therapeutics, INC. | $149.68 | 2023-2025 | Sunosi |
| Mallinckrodt Enterprises LLC | $115.82 | 2019 | |
| Vifor Pharma, INC. | $112.79 | 2024-2025 | Zemaira |
| Baxter Healthcare | $104.97 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Teva Pharmaceuticals USA, INC. | $94.23 | 2020-2023 | Airduo Digihaler |
| Jazz Pharmaceuticals INC. | $80.36 | 2021-2022 | |
| Medtronic USA, INC. | $79.03 | 2019 | |
| Optinose US, INC. | $75.12 | 2021-2024 | |
| Viatris Specialty LLC | $61.03 | 2025 | Yupelri |
| Gilead Sciences, INC. | $56.79 | 2019-2021 | |
| Philips North America LLC | $54.50 | 2019-2021 | |
| Zoll Respicardia, INC. | $53.28 | 2023-2024 | Remede System |
| Harmony Biosciences LLC | $48.67 | 2023-2024 | Wakix |
| Pulmonx Corporation | $48.01 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Allergan, INC. | $36.93 | 2020 | |
| Shire North American Group INC | $33.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.64 | 2021-2024 | Uptravi |
| Ethicon US, LLC | $27.96 | 2022 | |
| Abbvie INC. | $24.64 | 2021 | |
| Astellas Pharma US INC | $24.62 | 2019 | |
| Nabriva Therapeutics, Plc | $23.47 | 2022 | |
| Pinnacle Biologics, INC | $22.75 | 2021 | |
| Melinta Therapeutics, LLC | $22.67 | 2023 | Vabomere |
| Novartis Pharmaceuticals Corporation | $20.95 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.34 | 2023 | Nuzyra |
| Inogen, INC. | $18.43 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Biomerieux INC | $17.44 | 2020 | |
| Resmed Corp | $13.88 | 2021 | |
| Sanofi Pasteur INC. | $13.14 | 2019 | |
| Fisher & Paykel Healthcare INC | $12.14 | 2019 | |
| Circassia INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.